Why does public healthcare fail some patients?

A national health-spending increase does not answer every question about a local hospital. Funding, staffing, medicine availability and the cost a patient actually faces need different evidence.

The Ministry of Health’s 27 May 2026 release presents National Health Accounts estimates for 2022–23. That is the period being measured, not a description of all healthcare services in 2026. The figures below come from that official release; the full underlying report was not successfully retrieved for this collection. 1

What the spending figures actually compare

The release reports government health expenditure of roughly ₹3.85 lakh crore in 2022–23, compared with ₹1.30 lakh crore in 2013–14. These are rounded nominal amounts. They do not, without further adjustment, establish the increase in purchasing power or the amount reaching each facility. 1

Government spending’s share of total health expenditure increased from 28.6% to 43.7% across those years. That denominator is all health expenditure, not GDP and not the government’s whole budget. A chart must keep those distinctions visible. 1

The same spending can produce two GDP shares

The release gives 2022–23 government health expenditure as 1.43% of GDP, and also says it is 1.48% using the new GDP series with base year 2022–23. These are alternative presentations of the same year using different GDP denominators. They are not two consecutive years or evidence of an additional spending increase. 2

This is why the data card stores the GDP-series note beside the value. A single unlabeled field called “health spending percentage” would lose the distinction.

A long-term fall can coexist with a recent rise

Out-of-pocket expenditure means spending directly borne by households within the health-accounts measure. The release reports its share of total health expenditure as 64.2% in 2013–14, 39.4% in 2021–22, and 43.4% in 2022–23. 1

The long comparison shows a fall of 20.8 percentage points. The final two reported years show a rise of 4.0 percentage points. Both comparisons are valid when labelled; neither should be hidden to manufacture a preferred story.

A falling aggregate share also does not prove that every household’s bill fell. The total can change, costs can be distributed unevenly, and some people may not receive the care they need. Establishing those experiences requires additional evidence, not a reinterpretation of this percentage as a universal patient outcome.

Trace a facility-level failure

Identify the facility’s operator and relevant department. Then ask a narrow question: which posts were filled on the relevant date, what service hours were notified, or which stock and maintenance records cover the reported failure?

Keep dated receipts and public notices privately where they help, but redact patient identifiers before sharing. A doctor’s individual actions, a staffing gap and a procurement failure are different possible issues; the evidence should determine which one is being discussed.

For a public claim that access improved, ask for a defined measure of access and its coverage. For a claim that spending rose, ask for the period, denominator and accounting basis. Neither answer should be used as a substitute for the other.